Ensign Peak Advisors
CRGX

Ensign Peak Advisors’s CARGO Therapeutics CRGX Stock Holding History

Ensign Peak Advisors’s Portfolio CRGX Stock Details CRGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-50,000
Closed -$721K – 1694
2024
Q4 		$721K Hold
50,000
– – ﹤0.01% 1486
2024
Q3 		$923K Hold
50,000
– – ﹤0.01% 1371
2024
Q2 		$821K Hold
50,000
– – ﹤0.01% 1411
2024
Q1 		$1.12M Buy
+50,000
New +$1.19M ﹤0.01% 1244

Other funds holding CRGX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGV
TRV GP VI Boston, Massachusetts $136M AUM 328.39% 1-Year Est. Return

Ensign Peak Advisors's CRGX Position: Q1 2025 in Review

Ensign Peak Advisors sold out of CARGO Therapeutics (CRGX) in Q1 2025, closing a stake of 50,000 shares — an estimated $721K sold.

Ensign Peak Advisors first reported a position in CRGX in Q1 2024 and held it in 4 quarters. The position peaked at $1.12M in Q1 2024. 113 funds tracked by Wall St. Rank hold CRGX as of Q1 2025.

  • Ensign Peak Advisors reported no remaining CARGO Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Ensign Peak Advisors sold 50,000 CARGO Therapeutics shares in Q1 2025, an estimated $721K.
  • Ensign Peak Advisors first reported a position in CARGO Therapeutics in Q1 2024 and held it in 4 quarters.
  • Ensign Peak Advisors's CARGO Therapeutics position peaked at $1.12M in Q1 2024.
  • 113 funds tracked by Wall St. Rank held CARGO Therapeutics as of Q1 2025.

Based on Ensign Peak Advisors's 13F filing for Q1 2025, filed 14 May 2025.